CVS Corp (CVS) 102.63 $CVS
2 Small Biotech Stocks Dreaming Big in Hepatitis C
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - 2 hrs 27 mins ago
Hepatitis C treatment has progressed by leaps and bounds in the past few years, and appears to be accelerating even more quickly now. Cure rates have increased, treatment times are plummeting, and side effects are falling away. Is now the time to...
JNJ: 99.62 (+1.18), VRTX: 113.66 (+4.03), ISIS: 63.86 (-0.43), ALNY: 95.54 (+1.67), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), SHPG: 239.82 (+6.11), MRK: 58.81 (-0.07), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RGLS: 16.85 (-0.13)
The 10 Most Overpaid CEOs Running Multi-Billion Dollar Companies
at The Street - Fri Feb 13, 8:22AM CST
Which CEOs have the most egregious pay packages?
VIA: 69.08 (+1.02), MCK: 224.89 (+0.12), NBR: 12.73 (+0.52), FCX: 20.29 (+0.82), DISCA: 31.45 (+1.11), DIS: 104.17 (+0.59), CVS: 102.63 (-0.37), REGN: 402.40 (+0.66), ORCL: 43.93 (+0.04), CBS: 59.83 (+2.06)
5 Things CVS Health's Management Wants You to Know
Keith Speights, The Motley Fool - Motley Fool - Fri Feb 13, 6:02AM CST
Make it three in a row for CVS Health ! The large pharmacy retailer and pharmacy benefits manager beat earnings expectations for the third consecutive quarter when it announced fourth-quarter results on Tuesday. Company executives discussed those...
GILD: 101.90 (+1.10), CVS: 102.63 (-0.37)
CVS Health: Still A Buy At All-Time Highs?
Josh Arnold - at Seeking Alpha - Fri Feb 13, 5:52AM CST
CVS: 102.63 (-0.37)
Rite Aid (RAD) Jumps 6.6% on TPG's EnvisionRx Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 10:40AM CST
Rite Aid (RAD) announced that it has penned a deal with EnvisionRx, to buy the latter for roughly $2 billion.
ESRX: 84.90 (+0.40), WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Retail sales: What to like
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 8:43AM CST
DFRG: 19.14 (-0.03), PNRA: 155.02 (-2.31), CAB: 53.55 (+1.23), LL: 63.69 (+0.89), EAT: 59.16 (-0.18), JACK: 87.12 (-1.00), CAKE: 48.22 (-1.04), COSI: 2.80 (unch), PZZA: 62.11 (-1.11), LOCO: 24.20 (+0.06), LOW: 72.05 (-0.14), KKD: 21.06 (-0.28), YUM: 74.69 (-0.11), BGFV: 12.53 (+0.17), FRS: 27.79 (+0.29), DKS: 53.95 (+0.47), HABT: 30.87 (+0.10), RAD: 8.34 (+0.25), ZOES: 31.34 (+0.22), QSR: 38.74 (-0.58), WBA: 78.73 (-1.23), CBRL: 130.79 (-0.16), FRSH: 13.25 (-0.05), CVS: 102.63 (-0.37), ULTA: 136.66 (+0.59), BBRG: 13.49 (-0.01), BLMN: 24.45 (-0.16), WEN: 10.95 (-0.15), HIBB: 49.60 (+0.20), SBH: 33.10 (+0.28), BOBE: 56.41 (-0.68), BWLD: 187.27 (+0.30), SBUX: 91.58 (-0.24), NATH: 77.03 (-0.34), SONC: 31.59 (-0.37), IRG: 6.95 (-0.02), GTIM: 8.23 (+0.07), CMG: 674.89 (+4.60), DPZ: 100.00 (-0.56), PBPB: 13.92 (-0.07), SPWH: 7.22 (+0.01), TAST: 7.93 (+0.03), TXRH: 34.59 (+0.07), BDL: 34.03 (-0.42), RUTH: 15.73 (+0.88), HD: 111.89 (-0.27), RRGB: 77.77 (-0.20), CHUY: 22.04 (-0.35), PLKI: 61.07 (+0.44), DIN: 104.49 (-0.51), FRGI: 61.80 (-0.33), DENN: 10.68 (+0.03), DRI: 61.72 (+0.31), RT: 6.40 (+0.20), LUB: 5.03 (-0.03), NDLS: 25.96 (+0.23)
Rite Aid (RAD) Worth Watching: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:25AM CST
Rite Aid (RAD) was a big mover last session, with shares rising roughly 7% on the day.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Jim Cramer Explains Why Rite Aid (RAD) is Now a Growth Stock After Envision Acquisition
at The Street - Wed Feb 11, 3:22PM CST
TheStreet's Jim Cramer explains why he likes Rite Aid's (RAD) $2 billion acquisition of pharmacy benefit manager Envision Pharmaceutical Services.
CVS: 102.63 (-0.37), WAG: 76.05 (-0.49), RAD: 8.34 (+0.25)
CVS Health (CVS) Stock Rising Today After BMO Capital Markets Price Target Hike
at The Street - Wed Feb 11, 11:39AM CST
Shares of CVS Health (CVS) are gaining after BMO Capital Markets increased their price target to $113 from $103, and maintained an 'outperform' rating.
CVS: 102.63 (-0.37)
6 Ways Rite Aid's Acquisition Of EnvisionRx Will Take Its Stock Higher
Brian Nichols - at Seeking Alpha - Wed Feb 11, 11:15AM CST
GILD: 101.90 (+1.10), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RAD: 8.34 (+0.25)
3 Stocks Moving The Services Sector Upward
at The Street - Wed Feb 11, 11:10AM CST
TheStreet highlights 3 stocks pushing the services sector higher today.
WBA: 78.73 (-1.23), LB: 94.51 (-0.30), CVS: 102.63 (-0.37)
Rite Aid Sees Wider Margins in $2 Billion Envision Deal
at The Street - Wed Feb 11, 10:03AM CST
The cash-and-stock acquisition of the TPG Capital-backed pharmacy-benefit manager follows rival CVS' successful purchase of Caremark.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Today's Market: Earnings And Acquisitions Pushing These Names Higher
Matthew Smith - at Seeking Alpha - Wed Feb 11, 9:39AM CST
NFLX: 466.10 (+9.37), KO: 41.99 (-0.18), TSLA: 203.77 (+0.89), PIR: 12.52 (+0.17), LGF: 32.17 (+0.08), CVS: 102.63 (-0.37), STRZB: 30.37 (+1.95), TWX: 83.87 (+0.56), STRZA: 31.75 (-0.25), RAD: 8.34 (+0.25), PEP: 99.13 (-1.14)
Cramer: Rite Aid Continues to Impress, Shares Will Hit New Highs
at The Street - Wed Feb 11, 9:38AM CST
Jim Cramer applauds Rite Aid's management, saying the company is no longer in turnaround mode. The $2 billion acquisition of Envision will help to fuel its growth.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Stock Market News for February 11, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:10AM CST
Benchmarks rebounded on Tuesday after registering losses in the last two sessions as easing concerns about Greece’s debt negotiations boosted investor confidence
KO: 41.99 (-0.18), EXC: 33.51 (-0.93), PPL: 34.69 (-0.16), HAL: 44.19 (+1.42), XOM: 93.37 (+1.00), CVS: 102.63 (-0.37), DTE: 81.56 (-2.43), AAPL: 127.08 (+0.62), SO: 45.88 (-0.68), SLB: 88.38 (+2.42), BHI: 64.31 (+1.93)
Price targets moved higher on CVS Health
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 8:30AM CST
CVS: 102.63 (-0.37)
Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price
at The Street - Wed Feb 11, 8:04AM CST
Achillion Pharmaceuticals announced a 10 million-share stock offering Tuesday night.
ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00)
Rite Aid To Buy Pharmacy Benefits Manager EnvisionRX
at Investor's Business Daily - Wed Feb 11, 7:39AM CST
Rite Aid (RAD) announced Wednesday that it would buy independent pharmacy benefits manager EnvisionRx for $2 billion. The drugstore chain said it would purchase the privately held company, currently owned by the investment firm TPG, for $1.8 billion...
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Buy CVS Health After 4Q Revenue, Earnings Beat Expectations
at The Street - Wed Feb 11, 5:10AM CST
The drugstore chain's stock price reached a 52-week high and is expected to rise further.
WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
CVS Health: Smoke-Less Sales Drag Less Than Expected
at Investor's Business Daily - Tue Feb 10, 3:41PM CST
CVS Health said Tuesday the sales drag from its decision to stop selling tobacco products has been less than expected, bolstering efforts to rebrand itself as a health care company. The No. 2 U.S. drugstore operator's specialty pharmacy business also...
WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
2 Small Biotech Stocks Dreaming Big in Hepatitis C
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - 2 hrs 27 mins ago
Hepatitis C treatment has progressed by leaps and bounds in the past few years, and appears to be accelerating even more quickly now. Cure rates have increased, treatment times are plummeting, and side effects are falling away. Is now the time to...
JNJ: 99.62 (+1.18), VRTX: 113.66 (+4.03), ISIS: 63.86 (-0.43), ALNY: 95.54 (+1.67), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), SHPG: 239.82 (+6.11), MRK: 58.81 (-0.07), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RGLS: 16.85 (-0.13)
The 10 Most Overpaid CEOs Running Multi-Billion Dollar Companies
at The Street - Fri Feb 13, 8:22AM CST
Which CEOs have the most egregious pay packages?
VIA: 69.08 (+1.02), MCK: 224.89 (+0.12), NBR: 12.73 (+0.52), FCX: 20.29 (+0.82), DISCA: 31.45 (+1.11), DIS: 104.17 (+0.59), CVS: 102.63 (-0.37), REGN: 402.40 (+0.66), ORCL: 43.93 (+0.04), CBS: 59.83 (+2.06)
5 Things CVS Health's Management Wants You to Know
Keith Speights, The Motley Fool - Motley Fool - Fri Feb 13, 6:02AM CST
Make it three in a row for CVS Health ! The large pharmacy retailer and pharmacy benefits manager beat earnings expectations for the third consecutive quarter when it announced fourth-quarter results on Tuesday. Company executives discussed those...
GILD: 101.90 (+1.10), CVS: 102.63 (-0.37)
CVS Health: Still A Buy At All-Time Highs?
Josh Arnold - at Seeking Alpha - Fri Feb 13, 5:52AM CST
CVS: 102.63 (-0.37)
Rite Aid (RAD) Jumps 6.6% on TPG's EnvisionRx Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 10:40AM CST
Rite Aid (RAD) announced that it has penned a deal with EnvisionRx, to buy the latter for roughly $2 billion.
ESRX: 84.90 (+0.40), WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Retail sales: What to like
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 8:43AM CST
DFRG: 19.14 (-0.03), PNRA: 155.02 (-2.31), CAB: 53.55 (+1.23), LL: 63.69 (+0.89), EAT: 59.16 (-0.18), JACK: 87.12 (-1.00), CAKE: 48.22 (-1.04), COSI: 2.80 (unch), PZZA: 62.11 (-1.11), LOCO: 24.20 (+0.06), LOW: 72.05 (-0.14), KKD: 21.06 (-0.28), YUM: 74.69 (-0.11), BGFV: 12.53 (+0.17), FRS: 27.79 (+0.29), DKS: 53.95 (+0.47), HABT: 30.87 (+0.10), RAD: 8.34 (+0.25), ZOES: 31.34 (+0.22), QSR: 38.74 (-0.58), WBA: 78.73 (-1.23), CBRL: 130.79 (-0.16), FRSH: 13.25 (-0.05), CVS: 102.63 (-0.37), ULTA: 136.66 (+0.59), BBRG: 13.49 (-0.01), BLMN: 24.45 (-0.16), WEN: 10.95 (-0.15), HIBB: 49.60 (+0.20), SBH: 33.10 (+0.28), BOBE: 56.41 (-0.68), BWLD: 187.27 (+0.30), SBUX: 91.58 (-0.24), NATH: 77.03 (-0.34), SONC: 31.59 (-0.37), IRG: 6.95 (-0.02), GTIM: 8.23 (+0.07), CMG: 674.89 (+4.60), DPZ: 100.00 (-0.56), PBPB: 13.92 (-0.07), SPWH: 7.22 (+0.01), TAST: 7.93 (+0.03), TXRH: 34.59 (+0.07), BDL: 34.03 (-0.42), RUTH: 15.73 (+0.88), HD: 111.89 (-0.27), RRGB: 77.77 (-0.20), CHUY: 22.04 (-0.35), PLKI: 61.07 (+0.44), DIN: 104.49 (-0.51), FRGI: 61.80 (-0.33), DENN: 10.68 (+0.03), DRI: 61.72 (+0.31), RT: 6.40 (+0.20), LUB: 5.03 (-0.03), NDLS: 25.96 (+0.23)
Rite Aid (RAD) Worth Watching: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:25AM CST
Rite Aid (RAD) was a big mover last session, with shares rising roughly 7% on the day.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Jim Cramer Explains Why Rite Aid (RAD) is Now a Growth Stock After Envision Acquisition
at The Street - Wed Feb 11, 3:22PM CST
TheStreet's Jim Cramer explains why he likes Rite Aid's (RAD) $2 billion acquisition of pharmacy benefit manager Envision Pharmaceutical Services.
CVS: 102.63 (-0.37), WAG: 76.05 (-0.49), RAD: 8.34 (+0.25)
CVS Health (CVS) Stock Rising Today After BMO Capital Markets Price Target Hike
at The Street - Wed Feb 11, 11:39AM CST
Shares of CVS Health (CVS) are gaining after BMO Capital Markets increased their price target to $113 from $103, and maintained an 'outperform' rating.
CVS: 102.63 (-0.37)
6 Ways Rite Aid's Acquisition Of EnvisionRx Will Take Its Stock Higher
Brian Nichols - at Seeking Alpha - Wed Feb 11, 11:15AM CST
GILD: 101.90 (+1.10), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RAD: 8.34 (+0.25)
3 Stocks Moving The Services Sector Upward
at The Street - Wed Feb 11, 11:10AM CST
TheStreet highlights 3 stocks pushing the services sector higher today.
WBA: 78.73 (-1.23), LB: 94.51 (-0.30), CVS: 102.63 (-0.37)
Rite Aid Sees Wider Margins in $2 Billion Envision Deal
at The Street - Wed Feb 11, 10:03AM CST
The cash-and-stock acquisition of the TPG Capital-backed pharmacy-benefit manager follows rival CVS' successful purchase of Caremark.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Today's Market: Earnings And Acquisitions Pushing These Names Higher
Matthew Smith - at Seeking Alpha - Wed Feb 11, 9:39AM CST
NFLX: 466.10 (+9.37), KO: 41.99 (-0.18), TSLA: 203.77 (+0.89), PIR: 12.52 (+0.17), LGF: 32.17 (+0.08), CVS: 102.63 (-0.37), STRZB: 30.37 (+1.95), TWX: 83.87 (+0.56), STRZA: 31.75 (-0.25), RAD: 8.34 (+0.25), PEP: 99.13 (-1.14)
Cramer: Rite Aid Continues to Impress, Shares Will Hit New Highs
at The Street - Wed Feb 11, 9:38AM CST
Jim Cramer applauds Rite Aid's management, saying the company is no longer in turnaround mode. The $2 billion acquisition of Envision will help to fuel its growth.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Stock Market News for February 11, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:10AM CST
Benchmarks rebounded on Tuesday after registering losses in the last two sessions as easing concerns about Greece’s debt negotiations boosted investor confidence
KO: 41.99 (-0.18), EXC: 33.51 (-0.93), PPL: 34.69 (-0.16), HAL: 44.19 (+1.42), XOM: 93.37 (+1.00), CVS: 102.63 (-0.37), DTE: 81.56 (-2.43), AAPL: 127.08 (+0.62), SO: 45.88 (-0.68), SLB: 88.38 (+2.42), BHI: 64.31 (+1.93)
Price targets moved higher on CVS Health
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 8:30AM CST
CVS: 102.63 (-0.37)
Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price
at The Street - Wed Feb 11, 8:04AM CST
Achillion Pharmaceuticals announced a 10 million-share stock offering Tuesday night.
ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00)
Rite Aid To Buy Pharmacy Benefits Manager EnvisionRX
at Investor's Business Daily - Wed Feb 11, 7:39AM CST
Rite Aid (RAD) announced Wednesday that it would buy independent pharmacy benefits manager EnvisionRx for $2 billion. The drugstore chain said it would purchase the privately held company, currently owned by the investment firm TPG, for $1.8 billion...
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Buy CVS Health After 4Q Revenue, Earnings Beat Expectations
at The Street - Wed Feb 11, 5:10AM CST
The drugstore chain's stock price reached a 52-week high and is expected to rise further.
WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
CVS Health: Smoke-Less Sales Drag Less Than Expected
at Investor's Business Daily - Tue Feb 10, 3:41PM CST
CVS Health said Tuesday the sales drag from its decision to stop selling tobacco products has been less than expected, bolstering efforts to rebrand itself as a health care company. The No. 2 U.S. drugstore operator's specialty pharmacy business also...
WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
